GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Sky-high demand, a high price tag and tight supplies have created opportunities for bad actors to take advantage of consumers ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...